MBS608843 | Epidermal Growth Factor-Like Module-Containing Mucin-Like Receptor 3 (EGF-like Module Containing Mucin-like Hormone Receptor-like 3, EGF-like Module Containing Mucin-like Receptor 3, EMR3) (FITC)

Epidermal Growth Factor-Like Module-Containing Mucin-Like Receptor 3 (EGF-like Module Containing Mucin-like Hormone Receptor-like 3, EGF-like Module Containing Mucin-like Receptor 3, EMR3) (FITC) | MBS608843 | MyBiosource

Product Short Name: [Epidermal Growth Factor-Like Module-Containing Mucin-Like Receptor 3]

Product Name Synonyme: [Anti -Epidermal Growth Factor-Like Module-Containing Mucin-Like Receptor 3 (EGF-like Module Containing Mucin-like Hormone Receptor-like 3, EGF-like Module Containing Mucin-like Receptor 3, EMR3) (FITC)]

Other Names: [EGF-like module-containing mucin-like hormone receptor-like 2; EGF-like module-containing mucin-like hormone receptor-like 2; EGF-like module-containing mucin-like hormone receptor-like 2; egf-like module containing, mucin-like, hormone receptor-like 2; EGF-like module receptor 2]

Product Gene Name: N/A

Product Gene Name Synonyme: N/A

Other Gene Names: [EMR2; EMR2; CD312]

Clonality: Monoclonal

Isotype: IgG

Clone: [10C111]

Host: Hamster

Reactivity: Human

Specificity: Recognizes human epidermal growth factor (EGF) module-containing mucin-like hormone receptor 3 (EMR3).

Purity: Affinity Purified
Purified by Protein G affinity chromatography.

Form: Supplied as a liquid in PBS, pH 7.4, 0.09% sodium azide. Labeled with fluorescein isothiocyanate (FITC).

Concentration: N/A

Storage Stability: May be stored at 4 degree C for short-term only. For long-term storage and to avoid repeated freezing and thawing, add sterile 40-50% glycerol, aliquot and store at -20 degree C. Aliquots are stable for at least 12 months at -20 degree C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. FITC conjugates are sensitive to light.

Tested Application: Flow Cytometry (FC/FACS)